EDMOND PHARMA SRL

ACTIVE

STRADA STATALE 35 BIS DEI GIOVI 131, Paderno Dugnano, Milano, Italywww.edmondpharma.itPrivate

Clinical Trials

7 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Phase 1

42.9%

Trial Status Distribution

Active, not recruiting

100.0%

Clinical Trials

Trials sponsored by this organization (7)

The evaluation of efficacy and safety of erdosteine, a mucolytic anti-oxidant drug, in Chronic Bronchitis with Airway Obstructio

Active, not recruiting

Jul 2012542 participants

The evaluation of efficacy and safety of erdosteine, a mucolytic anti-oxidant drug, in Chronic Bronchitis with Airway Obstruction.

Active, not recruiting

May 2011542 participants

The efficacy and safety of erdosteine in the long term therapy of Chronic Obstructive Pulmonary Disease (COPD). A 12-month, randomised, double blind, placebo-controlled, parallel group, multicenter, study - Study RESTORE

Phase 1

Active, not recruiting

Feb 2011542 participants

The efficacy and safety of erdosteine in the long term therapy of Chronic Obstructive Pulmonary Disease (COPD). A 12-month, randomised, double blind, placebo-controlled, parallel group, multicenter, study - Study RESTORE

Active, not recruiting

Sep 2009542 participants

THE EFFICACY AND SAFETY OF ERDOSTEINE IN THE LONG-TERM THERAPY OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD).A 12-month, randomised, double-blind, placebo-controlled, parallel group, multicenter study. - Study RESTORE

Phase 1

Active, not recruiting

Jul 2009467 participants

The evaluation of efficacy and safety of erdosteine, a mucolytic anti-oxidant drug, in Chronic Bronchitis with Airway Obstruction.

Phase 1

Active, not recruiting

Jul 2009467 participants

THE EFFICACY AND SAFETY OF ERDOSTEINE IN THE LONG-TERM THERAPY OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD). A 12-month, randomized, double-blind, placebo-controlled, parallel group, multicenter study. - The RESTORE study

Active, not recruiting

Jun 2009542 participants

Approvals

Approvals by Agency

NMPA

National Medical Products Administration

Approvals

Recent Approvals

News

No news articles found

Back to Organizations